abstract |
The invention refers to an improved vaccine against infections with pathogens, especially viral pathogens, comprising an antigen, a peptide of the formula R1-XZXZN-XZX-R2 and an immunostimulatory deoxynucleic acid containing deoxyinosine and/or deoxyuridine residues. |